PHILADELPHIA — Leon Harris, de 35 años, conoce por experiencia personal la devastación que puede causar un arma. Hace casi dos décadas, unos ladrones le dispararon por la espalda, dejándolo paralizado del pecho hacia abajo. La bala aún permanece alojada en su columna. “Cuando te disparan, dejas de pensar en el futuro”, dijo. Su esposa,…
The move will save the behavioral healthcare company about $100 million over the next few years.
Virtual women’s health provider Midi Health has reached unicorn status after raising a $100 million Series D, with investors backing its insurance-covered, direct-to-consumer model. The company is positioning itself as a long-term, virtual “hospital without walls” designed to meet women’s health needs across midlife and beyond. The post Digital Health’s Latest Unicorn: Why Investors Are…
Dualitas Therapeutics designs bispecific antibodies to hit to two targets on the same immune cell, leveraging proximity biology to provide benefit beyond what’s possible with monoclonal antibody drugs. Eli Lilly and Chugai Pharmaceutical are among the investors in the immunology and inflammation startup. The post Two Is Better Than One: Startup Dualitas Lands $65M to…
While data and cost are important elements in recognizing issues, the measure of success isn’t just about the data or the numbers; it’s about ensuring that older adults can manage and maintain their expectations about health and aging in place. The post Beyond the Numbers: Every Data Point Tells a Different Story appeared first on…
[Sponsored] In this webinar, sponsored by Solera Health, executives will share how companies can make the most of healthcare benefits. The post Exploring The Next Generation of Healthcare Benefits appeared first on MedCity News.
Novartis drug Rhapsido is now approved as a second-line treatment for chronic spontaneous urticaria, a rare inflammatory skin disease. Additional clinical trials are ongoing to support potential expansion of the twice-daily pill to other immunological disorders. The post Novartis Nabs FDA Approval for First-of-Its-Kind Drug for Chronic Hives appeared first on MedCity News.
As an industry, we can and must do more. To be truly actionable, prices must be easily accessible, understandable, and patients need to be actively engaged to act on that information. The post Healthcare Price Transparency is More Than Showing a Price Tag appeared first on MedCity News.
Belgian sleep diagnostics company Sunrise announced the acquisition of Dreem Health, a California-based sleep clinic. This has allowed Sunrise to provide its telehealth-based sleep care in California, Iowa, Maryland and Washington, with plans to be available nationwide next year. The post Belgian Sleep Medicine Company Begins Providing Care In The US Through New Acquisition appeared…
AAMC says U. of Chicago Medicine and Pritzker School of Medicine embed community engagement into every aspect of medical education, research, and clinical care